The estimated Net Worth of Nicholas Khadder is at least $1.26 Milion dollars as of 8 January 2024. Mr. Khadder owns over 284 units of Standard BioTools Inc stock worth over $1,202 and over the last 11 years he sold FLDM stock worth over $0. In addition, he makes $1,257,780 as Senior Vice President, General Counsel a Corporate Secretary at Standard BioTools Inc.
Nicholas has made over 18 trades of the Standard BioTools Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 284 units of FLDM stock worth $1,054 on 8 January 2024.
The largest trade he's ever made was exercising 46,250 units of Standard BioTools Inc stock on 20 May 2021 worth over $171,588. On average, Nicholas trades about 2,719 units every 55 days since 2014. As of 8 January 2024 he still owns at least 324 units of Standard BioTools Inc stock.
You can see the complete history of Mr. Khadder stock trades at the bottom of the page.
Nicholas S. Khadder J.D. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. From 2010 to June 2016, Mr. Khadder held various positions at Amyris, Inc., an industrial biotechnology company, including senior vice president, general counsel and corporate secretary from 2013 to June 2016, interim general counsel from July 2013 to December 2013 and assistant general counsel from October 2010 to July 2013. Prior to joining Amyris, Mr. Khadder served in senior corporate counsel roles at LeapFrog Enterprises, Inc., an educational entertainment company, from August 2008 to September 2010, and at Protiviti, Inc., an internal audit and risk consulting firm, from June 2005 to July 2008. Before commencing his in-house legal career, Mr. Khadder was a corporate law associate at Fenwick & West LLP from 1998 to 2005. Mr. Khadder received a J.D. from Berkeley Law (the University of California, Berkeley, School of Law) and a B.A. in English from the University of California, Berkeley.
As the Senior Vice President, General Counsel a Corporate Secretary of Standard BioTools Inc, the total compensation of Nicholas Khadder at Standard BioTools Inc is $1,257,780. There are 4 executives at Standard BioTools Inc getting paid more, with Stephen Linthwaite having the highest compensation of $3,713,060.
Nicholas Khadder is 47, he's been the Senior Vice President, General Counsel a Corporate Secretary of Standard BioTools Inc since 2020. There are 10 older and 2 younger executives at Standard BioTools Inc. The oldest executive at Standard BioTools Inc is Vikram Jog, 65, who is the Chief Financial Officer.
Nicholas's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... a Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: